Evidence map›Paper›PMID 38596688›Full record

ArticleFrontiers in immunology2024

Differences in F pocket impact on HLA I genetic associations with autoimmune diabetes.

Xu Ren, A W Peshala Amarajeewa, M D Tharushika Jayasinghe, Malgorzata A Garstka

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xu RenDepartment of Urology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
A W Peshala AmarajeewaCore Research Laboratory, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
M D Tharushika JayasingheCore Research Laboratory, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Malgorzata A GarstkaDepartment of Urology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Second Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Human leukocyte antigen (HLA) I molecules present antigenic peptides to activate CD8 Methods: Here, we compared the T1D-predisposing and T1D-protective allotypes concerning peptide binding, maturation, localization and surface expression and correlated it with their sequences and energetic profiles using experimental and computational methods. Results: T1D-predisposing allotypes had more peptide-bound forms and higher plasma membrane levels than T1D-protective allotypes. This was related to the fact that position 116 within the F pocket was more conserved and made more optimal contacts with the neighboring residues in T1D-predisposing allotypes than in protective allotypes. Conclusion: Our work uncovers that specific polymorphisms in HLA I molecules potentially influence their susceptibility to T1D.

Indexed as

Diabetes Mellitus, Type 1CD8-Positive T-LymphocytesHistocompatibility AntigensHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA AntigensHumansPeptidesHistocompatibility AntigensHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA AntigensPeptidesantigen presentationautoimmune diabetesHLA class Iinflammationpeptide bindingpolymorphism

Identifiers

PMID38596688
PMCPMC11003304
OpenAlexW4393155682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.